FDA advisers unanimously back Cologuard, a DNA test for colon cancer Experimental therapies target chronic lymphocytic leukemiaMonoclonal antibody and kinase inhibitor yield promising results in recent trials Will better treatment phase out breast screening? CNBSS 25-year results question mammography programs Results mixed for bevacizumab in glioblastoma Angiogenesis inhibitor fails to prolong overall survival Giotrif: new oral therapy for metastatic lung cancer Targeted treatment improves progression-free survival and disease related symptoms. Earlier access to palliative care teams helps patients with advanced cancer cope Study finds quicker access improves quality of life and satisfaction with care. Concern raised over stroke risk with aromatase inhibitors Manitoba registry turns up findings not seen in trials Hormone therapy for breast cancer: When is five years enough? Ten-year treatment adds little benefit in early disease Unnecessary tests driving thyroid cancer epidemic Diagnosis rates vary widely but mortality remains constant Prostate cancer treatment takes its toll Avoid over-treating and watch for complications, researcher says First Previous 34 35 36 37 38 Next Last
